Eagle Pharmaceuticals, Inc. (EGRX) Investment Research Dashboard
About Eagle Pharmaceuticals, Inc. (EGRX) stock analysis
Get live EGRX stock price $0.37, comprehensive Eagle Pharmaceuticals, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time EGRX stock data and investment insights.
Loading chart data...
Eagle Pharmaceuticals, Inc. (EGRX) Overview
Eagle Pharmaceuticals, Inc. (EGRX) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, EGRX trades at $0.37 with a market capitalization of 4.87M . Over the past 52 weeks, EGRX has traded between $0.06 and $3.87 , with the current price positioned at approximately 8% of this range ....
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 4.87M
- Current price: $0.37
- 52-week range: $0.06 - $3.87
- P/E ratio: 5.29
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on manufacturing, developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The comp...
Company Information
- CEO
- Michael Graves
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 141
Contact Information
- Website
- https://www.eagleus.com
- Address
- 50 Tice Boulevard
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 5.3)
✓ Lower volatility stock (Beta: 0.63) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Eagle Pharmaceuticals, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Eagle Pharmaceuticals, Inc.
- ⚠Investors should consider how Eagle Pharmaceuticals, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
4.87M
P/E Ratio (TTM)
5.29
Beta
0.63
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare EGRX with peer companies:
- Price
- $0.17-8.84% (1D)
- Market cap
- 2.24M
- Price
- $0.02-4.44% (1D)
- Market cap
- 4.27M
- Price
- $0.00+0.00% (1D)
- Market cap
- 19.56K
- Price
- $0.05+8.07% (1D)
- Market cap
- 3.13M
- Price
- $0.67-16.72% (1D)
- Market cap
- 7.04M
- Price
- $0.03+2.44% (1D)
- Market cap
- 5.36M
- Price
- $0.00+0.00% (1D)
- Market cap
- 5.33M
- Price
- $0.02-8.37% (1D)
- Market cap
- 9.32M
- Price
- $0.00-3.03% (1D)
- Market cap
- 8.07M
- Price
- $0.00+0.00% (1D)
- Market cap
- 9.87K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
80/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +5.7% | +6.1% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | +2.9% | +4.3% | 22.2 | 86/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +3.3% | +3.5% | 24.1 | 80/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.1% | -0.2% | 25.2 | 56/100⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.7% | +1.2% | 29.7 | 56/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | -0.1% | -1.6% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -5.8% | -5.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | -3.0% | -5.9% | 26.8 | 28/100⭐⭐ |
| Industrials | +0.6% | +1.7% | -11.2% | 30.1 | 26/100⭐⭐ |
| Consumer Cyclical | +0.5% | -0.4% | -6.3% | 43.0 | 21/100⭐ |
| Technology | +0.6% | -2.3% | -9.6% | 40.7 | 17/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.